Terms: = Lung cancer AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2 AND Treatment
7 results:
1. The ranbp2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.
Blondel-Tepaz E; Leverve M; Sokrat B; Paradis JS; Kosic M; Saha K; Auffray C; Lima-Fernandes E; Zamborlini A; Poupon A; Gaboury L; Findlay J; Baillie GS; Enslen H; Bouvier M; Angers S; Marullo S; Scott MGH
Oncogene; 2021 Mar; 40(12):2243-2257. PubMed ID: 33649538
[TBL] [Abstract] [Full Text] [Related]
2. Crizotinib resistance in acute myeloid leukemia with inv(2)(p23q13)/RAN binding protein 2 (ranbp2) anaplastic lymphoma kinase (ALK) fusion and monosomy 7.
Takeoka K; Okumura A; Maesako Y; Akasaka T; Ohno H
Cancer Genet; 2015 Mar; 208(3):85-90. PubMed ID: 25766836
[TBL] [Abstract] [Full Text] [Related]
3. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
Yu X; Guo C; Yi H; Qian J; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2013 Apr; 73(7):2093-103. PubMed ID: 23333935
[TBL] [Abstract] [Full Text] [Related]
4. Targeting zinc finger domains with small molecules: solution structure and binding studies of the ranbp2-type zinc finger of RBM5.
Farina B; Fattorusso R; Pellecchia M
Chembiochem; 2011 Dec; 12(18):2837-45. PubMed ID: 22162216
[TBL] [Abstract] [Full Text] [Related]
5. Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine.
Yuan BZ; Jefferson AM; Popescu NC; Reynolds SH
Neoplasia; 2004; 6(4):412-9. PubMed ID: 15256063
[TBL] [Abstract] [Full Text] [Related]
6. Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells.
Wang RF; Wang HY
Nat Biotechnol; 2002 Feb; 20(2):149-54. PubMed ID: 11821860
[TBL] [Abstract] [Full Text] [Related]
7. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract] [Full Text] [Related]
